抗抑郁药的使用和发作风险:对观察性研究的元分析
Wei Yang1, Yong-Hui Jia2, Hai-Yin Jiang3
1Department of Oncology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China.
European journal of clinical pharmacology
|November 23, 2023
概括
像SSRI和SNRIs这样的新型抗抑郁药与更高的发作风险有关. 这种风险在短期使用 (30天以下) 时显著增加.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 临床研究 临床研究
背景情况:
- 抗抑郁药物和发作风险之间的关系尚未完全理解.
- 现有的研究对这种关联提出了相互矛盾的发现.
研究的目的:
- 进行元分析,调查抗抑郁药使用与发作风险之间的关联.
- 澄清不同类型抗抑郁药对风险的影响.
主要方法:
- 在PubMed和Embase数据库进行系统的文献搜索,截至2023年5月.
- 包括8项观察性研究,包括1,709,878名个人.
- 应用随机效应模型来估计整体相对风险.
主要成果:
- 选择性血清素再吸收抑制剂 (SSRI) 和选择性上腺素再吸收抑制剂 (SNRIs) 与发作风险增加有关.
- 三环抗抑郁药 (TCA) 与风险增加没有显著关联.
- 短期使用抗抑郁药 (少于30天) 显示,发作的几率比率大大提高.
结论:
- 这一元分析支持与新一代抗抑郁药相关的发作风险增加.
- 这些发现凸显出短期使用这些药物的患者中发作风险更明显.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
248
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
248
Antidepressant Drugs: Overview
516
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
516
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
403
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
403
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
317
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
317
Antiepileptic Drugs: Potassium Channel Activators
188
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
188
Sedatives and Hypnotics Drugs: Miscellaneous Agents
180
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
180


